Polyethylene Glycol Loxenatide Accelerates Diabetic Wound Healing by Downregulating Systemic Inflammation and Improving Endothelial Progenitor Cell Functions

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2025 Mar 13

PMID 40076985

Authors

Zerui Ding

Chunru Yang

Xiaojun Zhai

Yuqi Xia

Jieying Liu

Miao Yu

Affiliations

Soon will be listed here.

Abstract

Diabetes wound healing presents several significant challenges, which can complicate recovery and lead to severe consequences. Polyethylene glycol loxenatide (PEG-loxe), a long-acting glucagon-like peptide-1 receptor agonist (GLP-1RA), shows cardiovascular benefits, yet its role in diabetic wound healing remains unclear. Diabetic mice received PEG-loxe (0.03 mg/kg/week, i.p.) for three months. Glucose metabolism was evaluated using the insulin tolerance test (ITT) and oral glucose tolerance test (OGTT). Wound closure rates and angiogenesis-related proteins were analyzed. Serum proteomics was performed using the Olink assay to evaluate systemic inflammation. In vitro, human endothelial progenitor cells (EPCs) were exposed to high glucose and palmitic acid, with or without PEG-loxe treatment. EPC tube formation and migratory capacity were evaluated using the tube formation assay and migration assay, respectively. Levels of nitric oxide (NO) and phosphorylated endothelial nitric oxide synthase (p-eNOS) were quantified. Mitochondrial reactive oxygen species (ROS) production and mitochondrial membrane potential were assessed using MitoSOX and JC-1 staining. Cellular respiratory function was analyzed via the Seahorse XF assay. Autophagy was evaluated by examining the expression of autophagy-related proteins and the colocalization of mitochondria with lysosomes. PEG-loxe improved glucose tolerance, accelerated wound closure, and upregulated the hypoxia-inducible factor-1α/vascular endothelial growth factor/stromal cell-derived factor-1 axis (HIF-1α/VEGF/SDF-1) in diabetic mice. Serum proteomics revealed reduced pro-inflammatory markers and elevated anti-inflammatory IL-5. In vitro, PEG-loxe restored EPC function by enhancing NO production, reducing mitochondrial ROS, improving cellular respiratory function, and restoring autophagic flux. These findings suggest that PEG-loxe offers therapeutic benefits for diabetic wound healing by downregulating systemic inflammation, enhancing angiogenesis, and improving mitochondrial quality control in EPCs, highlighting GLP-1RAs as potential therapies for diabetic vascular complications.

References

Wils J, Favre J, Bellien J . Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes. Pharmacol Ther. 2016; 170:98-115. DOI: 10.1016/j.pharmthera.2016.10.014. View

Kingo K, Koks S, Nikopensius T, Silm H, Vasar E . Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes Immun. 2004; 5(2):117-21. DOI: 10.1038/sj.gene.6364046. View

Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili S, Mardani F . Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol. 2018; 233(9):6425-6440. DOI: 10.1002/jcp.26429. View

Onishi M, Yamano K, Sato M, Matsuda N, Okamoto K . Molecular mechanisms and physiological functions of mitophagy. EMBO J. 2021; 40(3):e104705. PMC: 7849173. DOI: 10.15252/embj.2020104705. View

Chaudhuri A, Ghanim H, Vora M, Sia C, Korzeniewski K, Dhindsa S . Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab. 2011; 97(1):198-207. PMC: 3251936. DOI: 10.1210/jc.2011-1508. View

Al Sadoun H . Macrophage Phenotypes in Normal and Diabetic Wound Healing and Therapeutic Interventions. Cells. 2022; 11(15). PMC: 9367932. DOI: 10.3390/cells11152430. View

Keermann M, Koks S, Reimann E, Prans E, Abram K, Kingo K . Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genomics. 2015; 16:322. PMC: 4405864. DOI: 10.1186/s12864-015-1508-2. View

Lin C, Lin F, Huang P, Chen Y, Chen W, Chen H . Endothelial progenitor cell dysfunction in cardiovascular diseases: role of reactive oxygen species and inflammation. Biomed Res Int. 2013; 2013:845037. PMC: 3591199. DOI: 10.1155/2013/845037. View

Fadini G, Miorin M, Facco M, Bonamico S, Baesso I, Grego F . Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol. 2005; 45(9):1449-57. DOI: 10.1016/j.jacc.2004.11.067. View

10.

Liu B, Li A, Qin Y, Chen L, Gao M, Gong G . Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome. J Vis Exp. 2022; (189). DOI: 10.3791/64647. View

11.

Bucher F, Lee J, Shin S, Kim M, Oh Y, Ha S . Interleukin-5 suppresses Vascular Endothelial Growth Factor-induced angiogenesis through STAT5 signaling. Cytokine. 2018; 110:397-403. DOI: 10.1016/j.cyto.2018.06.021. View

12.

Ceradini D, Kulkarni A, Callaghan M, Tepper O, Bastidas N, Kleinman M . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004; 10(8):858-64. DOI: 10.1038/nm1075. View

13.

Murphy E, Ardehali H, Balaban R, DiLisa F, Dorn 2nd G, Kitsis R . Mitochondrial Function, Biology, and Role in Disease: A Scientific Statement From the American Heart Association. Circ Res. 2016; 118(12):1960-91. PMC: 6398603. DOI: 10.1161/RES.0000000000000104. View

14.

Ussher J, Drucker D . Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action. Nat Rev Cardiol. 2023; 20(7):463-474. DOI: 10.1038/s41569-023-00849-3. View

15.

Sies H, Jones D . Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020; 21(7):363-383. DOI: 10.1038/s41580-020-0230-3. View

16.

Yue H, Zhang X, Zhao Z, Gong S, Shao S . Pro-healing impact of liraglutide on skin wounds in normoglycemic mice. Int Immunopharmacol. 2025; 147():114050. DOI: 10.1016/j.intimp.2025.114050. View

17.

Koks S . Genomics of Wolfram Syndrome 1 (WFS1). Biomolecules. 2023; 13(9). PMC: 10527379. DOI: 10.3390/biom13091346. View

18.

Xu F, Othman B, Lim J, Batres A, Ponugoti B, Zhang C . Foxo1 inhibits diabetic mucosal wound healing but enhances healing of normoglycemic wounds. Diabetes. 2014; 64(1):243-56. PMC: 4274809. DOI: 10.2337/db14-0589. View

19.

Verges B, Aboyans V, Angoulvant D, Boutouyrie P, Cariou B, Hyafil F . Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms. Cardiovasc Diabetol. 2022; 21(1):242. PMC: 9667639. DOI: 10.1186/s12933-022-01686-3. View

20.

Tecilazich F, Dinh T, Pradhan-Nabzdyk L, Leal E, Tellechea A, Kafanas A . Role of endothelial progenitor cells and inflammatory cytokines in healing of diabetic foot ulcers. PLoS One. 2013; 8(12):e83314. PMC: 3865213. DOI: 10.1371/journal.pone.0083314. View